Rabbit Recombinant Monoclonal iNOS antibody. Suitable for IP, ELISA, WB and reacts with Mouse, Rat, Recombinant fragment - Mouse samples. Cited in 6 publications.
View Alternative Names
Inosl, Nos2, Inducible NO synthase, Macrophage NOS, NOS type II, Peptidyl-cysteine S-nitrosylase NOS2, Inducible NOS, iNOS, MAC-NOS
- IP
Supplier Data
Immunoprecipitation - Anti-iNOS antibody [EPR16630] (AB205529)
iNOS was immunoprecipitated from 1mg of RAW 264.7 (Mouse macrophage cells transformed with Abelson murine leukemia virus) treated with 0.1 mg/ml LPS for 6 hours whole cell extract with ab205529 at 1/80 dilution. Western blot was performed from the immunoprecipitate using ab205529 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/10000 dilution.
Lane 1 : RAW 264.7 treated with 0.1 mg/ml LPS for 6 hours whole cell extract 10ug (Input).
Lane 2 : ab205529 IP in RAW 264.7 treated with 0.1 mg/ml LPS for 6 hours whole cell extract.
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab205529 in RAW 264.7 treated with 0.1 mg/ml LPS for 6 hours whole cell extract.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 8 seconds.
All lanes:
Immunoprecipitation - Anti-iNOS antibody [EPR16630] (ab205529)
Predicted band size: 131 kDa
false
- ELISA
Supplier Data
ELISA - Anti-iNOS antibody [EPR16630] (AB205529)
ELISA analysis of House mouse iNOS recombinant protein at 1000 ng/mL with ab205529. An Alkaline Phosphatase-conjugated AffiniPure Goat Anti-Rabbit IgG (H+L) at 1/2500 dilution was used as the secondary antibody.
- WB
Supplier Data
Western blot - Anti-iNOS antibody [EPR16630] (AB205529)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-iNOS antibody [EPR16630] (ab205529) at 1/1000 dilution
Lane 1:
Untreated RAW 264.7 (Mouse macrophage cells transformed with Abelson murine leukemia virus) whole cell lysate at 20 µg
Lane 2:
RAW 264.7 (Mouse macrophage cells transformed with Abelson murine leukemia virus) treated with 0.1 µg/ml LPS for 6 hours whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/50000 dilution
Predicted band size: 131 kDa
Observed band size: 131 kDa
true
Exposure time: 1s
- WB
Supplier Data
Western blot - Anti-iNOS antibody [EPR16630] (AB205529)
The molecular weight observed and the treatment method are consistent with what has been described in the literature (PMID : 12062366)
All lanes:
Western blot - Anti-iNOS antibody [EPR16630] (ab205529) at 1/1000 dilution
Lane 1:
Untreated L6 (rat skeletal muscle myoblast) whole cell lysate at 20 µg
Lane 2:
L6 treated with 50 ng/ml IL-1 beta, 20 ng/ml TNF-alpha and 100U/ml IFN-gamma for 24 h, whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 131 kDa
false
- WB
Lab
Western blot - Anti-iNOS antibody [EPR16630] (AB205529)
Blocking and dilution buffer : 5% NFDM/TBST iNOS is not normally expressed in the brain, but can be induced in the brain after inflammatory, infectious, or other damages (PMID : 11138926, PMID : 16156895, PMID : 10322315).
All lanes:
Western blot - Anti-iNOS antibody [EPR16630] (ab205529) at 1/1000 dilution
Lane 1:
Mouse hippocampus tissue lysate at 20 µg
Lane 2:
Mouse colon tissue lysate at 20 µg
Lane 3:
Mouse colon cancer tissue lysate at 20 µg
Observed band size: 131 kDa
false
Related conjugates and formulations (1)
-
Anti-iNOS antibody [EPR16630] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
INOS plays a significant role in the immune system by participating in the defense against pathogens. The enzyme is part of a molecular complex that generates NO which acts as a signaling molecule and has antimicrobial properties. iNOS activity is induced during immune responses and contributes to the elimination of bacteria and viruses through the production of reactive nitrogen species. Its expression is tightly regulated by cytokines and other signaling molecules that modulate the extent of its action.
Pathways
INOS integrates into the nitric oxide signaling pathway and is closely associated with inflammatory pathways. NO serves as a messenger within the nitric oxide signaling pathway facilitating processes like vasodilation and neurotransmission. iNOS works alongside other proteins such as cytokines like interferon-gamma that elevate its activity during inflammation and immune responses. The regulation of iNOS expression and activity plays an essential role in maintaining immune homeostasis and ensuring proper response to infections.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (6)
Recent publications for all applications. Explore the full list and refine your search
Journal of biochemical and molecular toxicology 38:e70062 PubMed39575578
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of radiation research 65:291-302 PubMed38588586
2024
Applications
Unspecified application
Species
Unspecified reactive species
Obesity facts 17:24-36 PubMed37820603
2023
Applications
Unspecified application
Species
Unspecified reactive species
Journal of healthcare engineering 2022:1890892 PubMed35368928
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cell metabolism 34:533-548.e12 PubMed35305295
2022
Applications
Unspecified application
Species
Unspecified reactive species
Journal of neuroinflammation 15:252 PubMed30180864
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com